Benjamin Salzer
Impact in
- Oncology top 10%
- CAR-T cell therapy research
-
- MicroRNA in disease regulation
Papers in
- Oncology 14
- CAR-T cell therapy research 13
- Peptidase Inhibition and Analysis 1
-
- Nanowire Synthesis and Applications 6
- Co-authors
- Manfred Lehner (13 shared papers)Charlotte U. Zajc (5 shared papers)Michael W. Traxlmayr (5 shared papers)Peter Dovjak (1 shared paper)Peter Pietschmann (1 shared paper)Wolfgang Holter (4 shared papers)Florian Hildner (1 shared paper)Regina Grillari‐Voglauer (1 shared paper)
- Journals
- Nature Communications (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancers (1 paper)Scientific Reports (1 paper)FEBS Journal (1 paper)
- Partner nations
- AustriaUnited StatesUnited Kingdom
In The Last Decade
Benjamin Salzer
14 papers receiving 439 citations
Peers
Comparison fields: 5 of 54
- Oncology 234
- Cancer Research 128
- Orthopedics and Sports Medicine 36
- Immunology 82
- Molecular Biology 239
Countries citing papers authored by Benjamin Salzer
This map shows the geographic impact of Benjamin Salzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Salzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Salzer more than expected).
Fields of papers citing papers by Benjamin Salzer
This network shows the impact of papers produced by Benjamin Salzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Salzer. The network helps show where Benjamin Salzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Salzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 160 | |
| 2 | 2020 | 69 | |
| 3 | 2020 | 68 | |
| 4 | 2023 | 31 | |
| 5 | 2020 | 31 | |
| 6 | 2020 | 23 | |
| 7 | 2024 | 12 | |
| 8 | 2018 | 11 | |
| 9 | 2020 | 11 | |
| 10 | 2023 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 7 | |
| 13 | 2023 | 4 | |
| 14 | 2024 | 1 | |
| 15 | 2022 | 0 |
About Benjamin Salzer
Benjamin Salzer is a scholar working on Oncology, Biomedical Engineering, Molecular Biology, Genetics and Immunology, having authored 15 papers that have together received 445 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (6 papers), Virus-based gene therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Advancements in Semiconductor Devices and Circuit Design (2 papers), Immune Cell Function and Interaction (2 papers), Peptidase Inhibition and Analysis (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Oncology (234 citations), Cancer Research (128 citations), Orthopedics and Sports Medicine (36 citations), Immunology (82 citations) and Molecular Biology (239 citations). Benjamin Salzer has collaborated with scholars based in Austria, United States and United Kingdom. Frequent co-authors include Manfred Lehner, Charlotte U. Zajc, Michael W. Traxlmayr, Peter Dovjak, Peter Pietschmann, Wolfgang Holter, Florian Hildner, Regina Grillari‐Voglauer, Susanna Skalicky and Matthias Hackl. Their work appears in journals such as Nature Communications, Proceedings of the National Academy of Sciences, Cancers, Scientific Reports and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.